Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Dual or Triple Therapy for Maintenance of COPD: A Review
Advertisement
Advertisement
Trending on AJMC
1
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
2
52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PV
3
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
4
As Milestone Nears, an Early Investigator Reflects on Lessons of Imatinib
5
